cytarabine and Tumor Lysis Syndrome

cytarabine has been researched along with Tumor Lysis Syndrome in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19901 (4.35)18.7374
1990's4 (17.39)18.2507
2000's5 (21.74)29.6817
2010's9 (39.13)24.3611
2020's4 (17.39)2.80

Authors

AuthorsStudies
Abernathy, KM; Byrne, M; Chen, H; Gatwood, KS; Perciavalle, MA; Zakhari, MM1
Ando, J; Asada, N; Dobashi, N; Honda, H; Iida, H; Ishizawa, K; Miyamoto, T; Mukai, H; Nishimura, Y; Okubo, S; Shinagawa, A; Soshin, T; Takada, S; Tsutsui, A; Usuki, K; Yamamoto, K; Yoshida, C1
Beutel, G; Eder, M; Gabdoulline, R; Gohring, G; Heuser, M; Koenecke, C; Krauter, J; Markel, D; Schlegelberger, B; Shahswar, R; Stadler, M; Thol, F; Trummer, A1
Diao, S; DiNardo, C; DiPippo, AJ; Konopleva, M; Maiti, A; Nichols, ED; Ning, J; Qiao, W1
Brierley, CK; Eyre, TA1
Altman, JK; Broun, ER; Carroll, MP; Karp, JE; Kaufmann, SH; Ketterling, RP; Lazarus, HM; Litzow, MR; Luger, SM; Paietta, EM; Pratz, KW; Rowe, JM; Rybka, WB; Tallman, MS; Tun, HW; Wang, XV; Zhang, Y1
Cairo, MS; Galardy, PJ; Goldman, S; Harrison, L; Hochberg, J; Perkins, SL1
Kline, RM; Simangan, LR1
Melendez-Rosado, JM; Stancampiano, FF; Zetir, M1
Choi, KA; Huh, W; Kim, DJ; Kim, K; Kim, WS; Kim, YG; Ko, YH; Lee, JE; Oh, HY1
Alino, K; Blackford, A; Bolaños-Meade, J; Carraway, HE; Doyle, LA; Gore, SD; Greer, JM; Jones, RJ; Karp, JE; Levis, MJ; McDevitt, MA; Seung, AH; Smith, BD; Wright, JJ1
van der Jagt, RH1
Alam, F; Chin, KJ1
Bai, QX; Chen, XQ; Gao, GX; Gu, HT; Liang, R; Shu, MM; Wang, WQ; Wang, YW; Yang, L; Zhang, T; Zhang, YQ; Zhu, HF1
Bruyere, H; Copland, M; Hogge, DE; Horsman, DE; Lavoie, JC; Le, A; Nantel, SH; Nevill, TJ; Seftel, MD; Shepherd, JD; Sutherland, HJ; Toze, CL1
Fujii, S; Kikuchi, T; Miyata, A1
Kiratli, PO1
Behringer, D; Fetscher, S; Finke, J; Kanz, L; Lange, W; Lübbert, M; Mertelsmann, R1
Ansoborlo, S; Babin-Boilletot, A; Baruchel, A; Pacquement, H; Patte, C; Plouvier, E; Sakiroglu, C1
Degos, L; Dombret, H; Dombret, MC; Faucher, C; Hunault, M1
Gonzales-Chambers, R; Przepiorka, D1
Longo, WL; McCroskey, RD; Mosher, DF; Prendergast, E; Spencer, CD1
Bachmann, F; Borgeat, A; Tran-Thang, C1

Trials

4 trial(s) available for cytarabine and Tumor Lysis Syndrome

ArticleYear
Venetoclax plus low-dose cytarabine in patients with newly diagnosed acute myeloid leukemia ineligible for intensive chemotherapy: an expanded access study in Japan.
    Japanese journal of clinical oncology, 2023, Jun-29, Volume: 53, Issue:7

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Japan; Leukemia, Myeloid, Acute; Middle Aged; Tumor Lysis Syndrome

2023
A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease.
    American journal of hematology, 2019, Volume: 94, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Disease-Free Survival; Etoposide; Female; Flavonoids; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Diseases; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Piperidines; Recurrence; Remission Induction; Salvage Therapy; Sirolimus; Topotecan; Tumor Lysis Syndrome

2019
Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children's Oncology Group Report.
    British journal of haematology, 2013, Volume: 163, Issue:3

    Topics: Acute Kidney Injury; Adolescent; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Female; Humans; Hydrocortisone; Hyperuricemia; Infant; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Proteins; Pilot Projects; Prednisone; Prospective Studies; Rituximab; Tumor Lysis Syndrome; Urate Oxidase; Vincristine; Young Adult

2013
Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia.
    Leukemia research, 2010, Volume: 34, Issue:7

    Topics: Adult; Aged; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Female; Flavonoids; Follow-Up Studies; Heart Diseases; Humans; Hyperkalemia; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Piperidines; Polyamines; Premedication; Remission Induction; Risk; Sepsis; Sevelamer; Transplantation, Homologous; Treatment Outcome; Tumor Lysis Syndrome; Young Adult

2010

Other Studies

19 other study(ies) available for cytarabine and Tumor Lysis Syndrome

ArticleYear
Real-world analysis of tumor lysis syndrome in patients started on venetoclax combination for acute myeloid leukemia.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2023, Volume: 29, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Leukemia, Myeloid, Acute; Retrospective Studies; Tumor Lysis Syndrome

2023
Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-up.
    Annals of hematology, 2021, Volume: 100, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Azacitidine; Bridged Bicyclo Compounds, Heterocyclic; Cytarabine; Decitabine; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Risk Factors; Sulfonamides; Tumor Lysis Syndrome

2021
Incidence of tumor lysis syndrome in patients with acute myeloid leukemia undergoing low-intensity induction with venetoclax.
    American journal of hematology, 2021, 03-01, Volume: 96, Issue:3

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cytarabine; Decitabine; Female; Fluid Therapy; Humans; Hydroxyurea; Incidence; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Leukocytosis; Male; Middle Aged; Phosphate-Binding Proteins; Phosphorus; Proto-Oncogene Proteins c-bcl-2; Retrospective Studies; Sulfonamides; Tumor Lysis Syndrome; Urate Oxidase; Uric Acid

2021
Acute monoblastic leukemia presenting with striking periorbital and periauricular infiltration.
    Blood, 2017, 06-22, Volume: 129, Issue:25

    Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Ear, External; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hearing Loss, Unilateral; Humans; Idarubicin; Leukemia, Monocytic, Acute; Leukemic Infiltration; Male; Orbit; Tumor Lysis Syndrome; Vidarabine

2017
Tumor Lysis Syndrome: An Unreported Complication of Intrathecal Ara-C.
    Journal of pediatric hematology/oncology, 2015, Volume: 37, Issue:3

    Topics: Adolescent; Antimetabolites, Antineoplastic; Cytarabine; Humans; Injections, Spinal; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Tumor Lysis Syndrome

2015
50-Year-Old Man With New-Onset Acute Kidney Injury.
    Mayo Clinic proceedings, 2015, Volume: 90, Issue:10

    Topics: Acute Kidney Injury; Antineoplastic Agents; Cisplatin; Cytarabine; Dexamethasone; Gout Suppressants; Humans; Lymphoma, T-Cell; Male; Middle Aged; Rehydration Solutions; Treatment Outcome; Tumor Lysis Syndrome; Urate Oxidase; Water-Electrolyte Imbalance

2015
Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome.
    Annals of hematology, 2009, Volume: 88, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hemofiltration; Humans; Hydrocortisone; Hyperuricemia; Kidney Function Tests; Leucovorin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Risk; Survival Analysis; Tumor Lysis Syndrome; Vincristine

2009
Sequential flavopiridol, mitoxantrone and cytosine arabinoside for newly diagnosed poor risk acute myeloid leukemia. What to do next?
    Leukemia research, 2010, Volume: 34, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Flavonoids; Follow-Up Studies; Forecasting; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Piperidines; Risk; Treatment Outcome; Tumor Lysis Syndrome

2010
Acute intraoperative tumour lysis syndrome.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2010, Volume: 57, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Hydroxyurea; Leukemia, Myeloid, Acute; Middle Aged; Postoperative Complications; Risk Factors; Time Factors; Tumor Lysis Syndrome

2010
Reduced tumor lysis syndrome with low dose chemotherapy for hyperleukocytic acute leukemia prior to induction therapy.
    Asian Pacific journal of cancer prevention : APJCP, 2011, Volume: 12, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cytarabine; Etoposide; Female; Humans; Induction Chemotherapy; Leukemia, Promyelocytic, Acute; Leukostasis; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Tumor Lysis Syndrome; Young Adult

2011
Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22).
    European journal of haematology, 2002, Volume: 69, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Agents; Chromosome Inversion; Chromosomes, Human, Pair 16; Cytarabine; Daunorubicin; Female; Genetic Predisposition to Disease; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Tumor Lysis Syndrome

2002
[Acute myelogenous leukemia complicated with severe tumor lysis syndrome after a single day of idarubicin/cytarabine chemotherapy].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2003, Volume: 44, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Tumor Lysis Syndrome

2003
Gallium imaging in a patient with tumor lysis syndrome.
    Clinical nuclear medicine, 2007, Volume: 32, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Citrates; Cytarabine; Gallium; Humans; Lymphoma, B-Cell; Male; Methotrexate; Radionuclide Imaging; Radiopharmaceuticals; Tumor Lysis Syndrome

2007
Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation.
    Bone marrow transplantation, 1997, Volume: 19, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Injections, Spinal; Lymphoma, B-Cell, Marginal Zone; Male; Melphalan; Methotrexate; Prednisone; Recurrence; Remission Induction; Retreatment; Salvage Therapy; Stomach Neoplasms; Transplantation Conditioning; Tumor Lysis Syndrome; Vincristine

1997
Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; France; Humans; Hydrocortisone; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Tumor Lysis Syndrome; Urate Oxidase; Vincristine

2002
Acute lysis pneumopathy after chemotherapy for acute myelomonocytic leukemia with abnormal marrow eosinophils.
    Cancer, 1992, Mar-15, Volume: 69, Issue:6

    Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cough; Cytarabine; Daunorubicin; Eosinophils; Female; Humans; Hypoxia; Leukemia, Myelomonocytic, Acute; Respiratory Insufficiency; Tumor Lysis Syndrome

1992
Acute tumor lysis syndrome in a patient with chronic myelogenous leukemia in blast crisis: role of high-dose Ara-C.
    Bone marrow transplantation, 1990, Volume: 6, Issue:4

    Topics: Acute Disease; Adult; Blast Crisis; Bone Marrow Transplantation; Cytarabine; Dose-Response Relationship, Drug; Graft vs Host Disease; Humans; Kidney Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Tumor Lysis Syndrome

1990
Acute tumor lysis syndrome and treatment response in patients treated for refractory chronic lymphocytic leukemia with short-course, high-dose cytosine arabinoside, cisplatin, and etoposide.
    Cancer, 1990, Jul-15, Volume: 66, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocyte Count; Male; Middle Aged; Neutropenia; Tumor Lysis Syndrome

1990
[Acute monoblastic leukemia complicated by fatal splenic rupture following initiation of chemotherapy].
    Schweizerische medizinische Wochenschrift, 1989, Feb-18, Volume: 119, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Doxorubicin; Humans; Leukemia, Monocytic, Acute; Male; Spleen; Splenic Rupture; Tumor Lysis Syndrome

1989